|
|
|
|
Science Sparks @ ACTREC
|
 18th March 2024 |
Vol. No. 13 ; Issue No.622 |
|
|
Publications
|
|
1. Natu K, Dutta S, Bose K (2024). cFLIP – An interacting partner and a novel substrate for pro-apoptotic serine protease HtrA2 . Biochemistry and Biophysics Reports. 38: 101682.
2. Sandhbhor P, Palkar P, Bhat S, John G, Goda J (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale.
3. Rai A, Patwardhan R, Jayakumar S, Pachpatil P, Das D, Panigrahi G, Gota V, S Patwardhan, Sandur S (2024). Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis. Acta Pharmacologica Sinica.
4. Gupta T, Chatterjee A (2024). Existing and evolving landscape of medulloblastoma: Towards optimization and personalization. Diagnostics. 14(6): 598
5. Dixit J, Gupta N, Kataki A, Roy P, Mehra N, Kumar L, Singh A, Malhotra P, Gupta D, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S, Prinja S(2024). Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database. Health and Quality of Life Outcomes. 22(1):26
6. Hande V, Ranjan N, Chopra S, Sinha S, Mittal P, Gupta A, Maheshwari A, Gupta S (2024). Longitudinal costs of image-guided intensity-modulated radiation therapy versus three-dimensional conformal radiation: Lessons from phase III PARCER trial for shaping resource-stratified guidelines in low- and middle-income countries. JCO Global Oncology.
7. Desai S, Ahmad S, Bawaskar B, Rashmi S, Mishra R, Lakhwani D, Dutt A. Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. NAR Cancer. 6(1):zcae010.
|
|
|
|
|
Interesting Reads
|
|
Nakandakari-Higa S, Walker S, Canesso MCC, van der Heide V, Chudnovskiy A, Kim DY, Jacobsen JT, Parsa R, Bilanovic J, Parigi SM, Fiedorczuk K, Fuchs E, Bilate AM, Pasqual G, Mucida D, Kamphorst AO, Pritykin Y, Victora GD (2024). Univer sal recording of immune cell interactions in vivo. Nature.
|
|
|
Video of the Week
|
|
| Modulating Cancer Networks with Molecular Glues |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1978, Researchers developed and carry out the first trial of tamoxifen to prevent recurrence in breast cancer survivors.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Researchers shed light on cancer cell survival in early hypoxia.
|
|
News-Medical, 14/03/2024
|
|
By studying how cancer cells use nutrients, the researchers found that, within three hours of the cells being deprived of oxygen, a process called glycolysis (breaking down glucose to make energy) increases. HIF1α has been known to drive increased glycolysis when cells are chronically exposed to low oxygen...
|
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
